Cargando…
TWEAK/Fn14 pathway modulates properties of a human microvascular endothelial cell model of blood brain barrier
BACKGROUND: The TNF ligand family member TWEAK exists as membrane and soluble forms and is involved in the regulation of various human inflammatory pathologies, through binding to its main receptor, Fn14. We have shown that the soluble form of TWEAK has a pro-neuroinflammatory effect in an animal mo...
Autores principales: | Stephan, Delphine, Sbai, Oualid, Wen, Jing, Couraud, Pierre-Olivier, Putterman, Chaim, Khrestchatisky, Michel, Desplat-Jégo, Sophie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570290/ https://www.ncbi.nlm.nih.gov/pubmed/23320797 http://dx.doi.org/10.1186/1742-2094-10-9 |
Ejemplares similares
-
Is TWEAK a Biomarker for Autoimmune/Chronic Inflammatory Diseases?
por: Bertin, Daniel, et al.
Publicado: (2013) -
Neuropsychiatric Lupus, the Blood Brain Barrier, and the TWEAK/Fn14 Pathway
por: Stock, Ariel D., et al.
Publicado: (2013) -
High levels of serum soluble TWEAK are associated with neuroinflammation during multiple sclerosis
por: Maarouf, Adil, et al.
Publicado: (2019) -
TWEAK and Fn14 in the Neurovascular Unit
por: Yepes, Manuel
Publicado: (2013) -
TWEAK and TNFα, Both TNF Ligand Family Members and Multiple Sclerosis-Related Cytokines, Induce Distinct Gene Response in Human Brain Microvascular Endothelial Cells
por: Stephan, Delphine, et al.
Publicado: (2022)